Soleus Capital Management’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.9M Buy
667,835
+81,877
+14% +$2.02M 0.71% 36
2026
Q2
$13.2M Buy
585,958
+169,359
+41% +$2.51M 0.46% 51
2026
Q1
$6.04M Buy
+416,599
New +$5.16M 0.24% 60
2024
Q4
– Sell
-201,903
Closed -$7.19M – 88
2024
Q3
$7.19M Sell
201,903
-103,695
-34% -$3.57M 0.56% 47
2024
Q2
$9.35M Buy
+305,598
New +$8.73M 0.82% 40

Other funds holding BDSX

Soleus Capital Management's BDSX Position: Q3 2026 in Review

Soleus Capital Management increased its Biodesix (BDSX) stake by 14% in Q3 2026, buying an estimated $2.02M and bringing the position to 667,835 shares worth $19.9M. The position accounts for 0.71% of the portfolio, ranked #36.

Soleus Capital Management first reported a position in BDSX in Q2 2024 and has held it in 5 quarters since. 61 funds tracked by Wall St. Rank hold BDSX as of Q3 2026.

  • Soleus Capital Management held 667,835 shares of Biodesix worth $19.9M as of Q3 2026.
  • Soleus Capital Management bought 81,877 Biodesix shares in Q3 2026, an estimated $2.02M.
  • Biodesix made up 0.71% of Soleus Capital Management's portfolio in Q3 2026, its #36 holding.
  • Soleus Capital Management first reported a position in Biodesix in Q2 2024 and has held it in 5 quarters since.
  • 61 funds tracked by Wall St. Rank held Biodesix as of Q3 2026.

Based on Soleus Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.